• SUN5 overexpression enhances glycolysis in colorectal cancer cells, while knockdown reduces it.
• SUN5 interacts with TRIM28 to promote IκBα ubiquitination, activating NF-κB signaling.
• NF-κB activation upregulates GLUT1 and LDHA, accelerating glycolysis and tumor growth.
• SUN5 is a potential therapeutic target for colorectal cancer diagnosis and treatment.